Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Providence Health Care Test Catalog
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
Myeloma Explained | Haematology | Oncology | onthewards
Serum free light chain level at diagnosis in myeloma cast nephropathy—a multicentre study | Blood Cancer Journal
Table 5 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Evolution of kappa, lambda light chain level and kappa/lambda ratio (A)... | Download Scientific Diagram
Final Diagnosis -- Case 701
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Serum free light chain measurement aids the diagnosis of myeloma in patients with severe renal failure | BMC Nephrology | Full Text
Modeling the Effects of Multiple Myeloma on Kidney Function | Scientific Reports
Monoclonal gammopathy of renal significance: Early diagnosis is key
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Table 2 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Examples of abnormal kappa/lambda free light chain (κ/λ FLC) ratios in... | Download Table
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Kappa/lambda serum FLC ratio in patients with IgG4-RD. Comparison of... | Download Scientific Diagram
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Distribution of serum FLC and kappa/lambda ratio in patients with renal... | Download Table
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
